Service · Medical Weight Loss · Marietta, GA
Retatrutide in Marietta, GA
Medically reviewed by Dr. Nokuthula Msimanga, MD — Medical Director · Last reviewed July 3, 2026
Retatrutide in Marietta starts at $399/month at Majspa — a physician-supervised program built around the next-generation triple agonist (GLP-1 + GIP + glucagon). Mid-stage trial participants averaged roughly 24% body weight reduction at 48 weeks, the largest reported for any weight-loss medication. Not yet FDA-approved; prescribed for appropriate candidates after an individualized risk-benefit consult.
Physician-supervised retatrutide at Majspa Medspa & Aesthetics in Marietta — once-weekly injections with monthly titration visits, labs, and close monitoring. Transparent flat monthly pricing. Serving Marietta, East Cobb, Kennesaw, Roswell, and metro Atlanta.
Starting at
From $399/mo
Dosing
Once-weekly injection
Visits
Monthly
Trial average
~24% body weight
Status
Late-stage trials
Searching for retatrutide near you in Marietta? Retatrutide is the most talked-about medication in weight management — a triple receptor agonist ("triple G") that activates GLP-1, GIP, and glucagon receptors at once. It posted the largest average weight loss ever reported in a clinical trial. It is also the newest and least-proven of the three medications we offer, which is exactly why it belongs in a physician-supervised program rather than a mail-order checkout.
An honest word on where retatrutide stands
Retatrutide is not yet FDA-approved — it is completing late-stage (Phase 3) clinical trials. Where clinically appropriate, it can be prescribed under close physician supervision through licensed compounding channels. At your consult, Dr. Msimanga walks through the published trial evidence, the monitoring plan, and whether an FDA-approved option — semaglutide or tirzepatide — is the smarter starting point for you. Many clients begin on an approved medication and step up only if they plateau.
Why Majspa for retatrutide in Marietta
- Physician-led, genuinely. Triple board-certified Dr. Nokuthula Msimanga, MD personally manages retatrutide patients — intake labs, titration, and the added monitoring a newer medication deserves.
- Individualized risk-benefit consult before any prescription — including whether you should be on this medication at all.
- Licensed pharmacies only. Sourced exclusively through licensed 503A/503B compounding pharmacies.
- Flat monthly fee. From $399/month including the medication, the visit, and support.
- CareCredit financing available across the program.
How retatrutide works
Like semaglutide, retatrutide activates GLP-1 (fullness, slower stomach emptying). Like tirzepatide, it adds GIP (insulin response, fat metabolism). Its third mechanism is what's new: glucagon receptor activity, which increases energy expenditure — your body burns more, not just eats less. In published mid-stage trial data, participants on the higher doses averaged roughly 24% body weight reduction at 48 weeks, with weight still trending down at the study's end.
Pricing — Marietta, GA
| Program | Monthly fee |
|---|---|
| Retatrutide program (medication + monthly visit + support) | From $399/mo |
| Tirzepatide program (FDA-approved dual agonist) | From $299/mo |
| Semaglutide program (FDA-approved GLP-1) | From $199/mo |
Dose tier can adjust the fee; finalized at your complimentary consult. CareCredit accepted.
Where we serve
Our Marietta studio is convenient to clients across Cobb County and metro Atlanta:
What to expect
- Complimentary consult. Medical history, goals, and an honest risk-benefit discussion of retatrutide vs. the FDA-approved alternatives.
- Intake labs. Standard panel (CBC, CMP, A1C, lipids, thyroid) plus baseline liver values, given retatrutide's glucagon activity.
- Start at the starter dose. Injection training and a side-effect playbook at your first visit.
- Monthly titration visits. Weight, blood pressure, heart rate, side-effect review, and dose adjustment.
- Maintenance & off-ramp. A structured plan for sustaining results — including a taper protocol if you choose to come off medication.
Frequently asked questions
What does retatrutide cost in Marietta?
Our retatrutide program starts at $399/month — a flat fee that includes the medication, the monthly physician visit, and ongoing support. Dose tier can adjust the fee; we finalize pricing at your complimentary consult and accept CareCredit.
What is retatrutide?
Retatrutide is a next-generation triple receptor agonist — it activates GLP-1, GIP, and glucagon receptors simultaneously. The added glucagon activity increases energy expenditure on top of the appetite suppression GLP-1 medications are known for. In published mid-stage clinical trial data, participants averaged roughly 24% body weight reduction at 48 weeks — the largest reported for any weight-loss medication.
Is retatrutide FDA-approved?
Not yet — retatrutide is completing late-stage clinical trials and does not have FDA approval at this time. Where clinically appropriate, it can be prescribed under close physician supervision through licensed compounding channels. Dr. Msimanga discusses the risk-benefit profile, the trial evidence, and whether an FDA-approved alternative (semaglutide or tirzepatide) is the better fit at your consult.
Who is a candidate for retatrutide?
Retatrutide is generally considered for patients who want maximum efficacy and understand its newer evidence base — often those who have plateaued on semaglutide or tirzepatide. Standard program criteria apply (BMI ≥27 with a weight-related condition, or BMI ≥30), plus an individualized risk-benefit discussion with our physician.
What are the side effects of retatrutide?
Trial data show a side-effect profile similar to other GLP-1-class medications: nausea, constipation, fatigue, and reduced appetite, mostly mild-to-moderate and dose-dependent. Because retatrutide also activates glucagon receptors, we monitor heart rate and liver values as part of routine follow-up. We screen at intake and at every monthly visit.
Retatrutide vs. tirzepatide vs. semaglutide — how do they compare?
Average body-weight reduction in trials: semaglutide ~15%, tirzepatide ~20%, retatrutide ~24% (mid-stage data). Monthly fee at Majspa: $199, $299, and $399 respectively. Semaglutide and tirzepatide are FDA-approved; retatrutide is not yet. Our physician helps you pick the right starting point — many clients begin on an approved medication and step up only if needed.
Ask about retatrutide in Marietta
Book a complimentary consultation. We'll review your history, compare all three medications honestly, and quote your exact monthly fee.